Related Experiment Video
Updated: Sep 13, 2025

Author Spotlight: Elucidating the Pathways of TFH Cell Differentiation in Acute LCMV Challenges
Published on: April 26, 2024
Early-life human CD8+ T cells exhibit rapid, short-lived effector responses and a unique transcription factor
Nina N Brodsky1,2, Monisha Chakder1,2, Dinesh Babu Uthaya Kumar2
1Pediatrics Department, Yale University School of Medicine, New Haven, CT 06520.
Insights
Neonatal CD8+ T cells show unique molecular programs for rapid responses to viral infections. These cells have an accelerated effector switch and short-lived program, offering insights into early-life immunity.
Area of Science:
- Immunology
- Cellular Biology
- Neonatal Medicine
Background:
- Neonates and infants exhibit distinct cellular and clinical responses to viral infections compared to adults.
- Neonatal CD8+ T cells possess innate-like characteristics and a low activation threshold, but the underlying molecular mechanisms are not fully understood.
- Early-life immune responses may prioritize minimizing tissue damage, especially during passive maternal antibody-mediated immunity.
Purpose of the Study:
- To define the unique response characteristics and transcription factor landscape of neonatal human CD8+ T cells.
- To identify molecular pathways that drive distinct early-life immune responses to viral infections.
- To explore potential therapeutic targets for modulating viral illnesses in neonates.
Main Methods:
- Comparative analysis of gene expression and protein markers in neonatal versus adult CD8+ T cells.
- Assessment of T cell activation, proliferation, cell death, and viability.
- Investigation of the transcription factor landscape, including TOX and HELIOS expression.
Main Results:
- Naïve neonatal CD8+ T cells display an accelerated effector switch, with elevated levels of KLRG1, KLRB1, FCER1G, DNAM1, granzymes, TNFα, IL-2, and glycolysis compared to adults.
- Activated neonatal CD8+ T cells undergo rapid proliferation and cell death, with viability rescued by IL-2 or IL-7.
- Neonatal CD8+ T cells exhibit a unique transcription factor profile, with high expression of TOX and HELIOS (IKZF2), persisting for at least 2 months postnatally.
Conclusions:
- Early-life human CD8+ T cells maintain a distinct transcriptional state characterized by an accelerated effector switch and a short-lived effector program.
- These findings reveal key regulatory nodes governing the unique immunobiology of neonatal CD8+ T cells.
- Understanding these pathways is crucial for developing strategies to manage viral infections in vulnerable infant populations.
Abstract:
Neonates and infants are distinct in their clinical and cellular responses to viral infections, with neonatal CD8+ T cells displaying innate-like characteristics and a low threshold for T cell receptor activation. However, specific molecular programs that drive these unique responses are incompletely understood, particularly in humans, and targetable pathways to modulate viral illness in this vulnerable population remain to be elucidated. Early-life immune responses may be developmentally programmed to prioritize avoidance of tissue immunopathology, especially while maternal immunoglobulin provides passive immunity. We set out to define the unique response characteristics and transcription factor landscape of neonatal human CD8+ T cells. Here, we report evidence that naïve neonatal human CD8+ T cells are poised for an accelerated effector switch, with elevations of killer cell lectin-like receptor G1 (KLRG1), killer cell lectin-like receptor B1 (KLRB1/CD161), Fc epsilon receptor I-gamma (FCER1G), DNAX accessory molecule-1 (DNAM1/CD226), granzymes, tumor necrosis factor alpha (TNFα), interleukin 2 (IL-2), and glycolysis compared to naïve adult CD8+ T cells. Further, rapid proliferation and cell death occur upon activation of neonatal CD8+ T cells, with cell viability largely rescued by IL-2 or IL-7. These features are coupled with a unique transcription factor landscape, including high expression of thymocyte selection associated high mobility group box (TOX) and HELIOS (IKZF2), and these signatures continue in postnatal life until at least 2 mo of age. We conclude that early-life human CD8+ T cells maintain a unique transcriptional state associated with an accelerated effector switch and short-lived effector program, revealing key nodes of regulation relevant for the unique immunobiology of neonatal humans.
Related Concept Videos
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Special Features of Adaptive Immunity
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Cells of the Adaptive Immune Response
General Transcription Factors
Cell-mediated Immune Responses

